Suivre
B. Rael Cahn
Titre
Citée par
Citée par
Année
Meditation states and traits: EEG, ERP, and neuroimaging studies.
BR Cahn, J Polich
Educational Publishing Foundation 1 (S), 48, 2013
27202013
Occipital gamma activation during Vipassana meditation
BR Cahn, A Delorme, J Polich
Cognitive processing 11, 39-56, 2010
3472010
Meditation (Vipassana) and the P3a event-related brain potential
BR Cahn, J Polich
International journal of psychophysiology 72 (1), 51-60, 2009
2842009
Effects of psilocybin on time perception and temporal control of behaviour in humans
M Wittmann, O Carter, F Hasler, BR Cahn, U Grimberg, P Spring, D Hell, ...
Journal of Psychopharmacology 21 (1), 50-64, 2007
2762007
Yoga, meditation and mind-body health: increased BDNF, cortisol awakening response, and altered inflammatory marker expression after a 3-month yoga and meditation retreat
BR Cahn, MS Goodman, CT Peterson, R Maturi, PJ Mills
Frontiers in human neuroscience 11, 315, 2017
2272017
Increased gamma brainwave amplitude compared to control in three different meditation traditions
C Braboszcz, BR Cahn, J Levy, M Fernandez, A Delorme
PloS one 12 (1), e0170647, 2017
1752017
Awakening is not a metaphor: the effects of Buddhist meditation practices on basic wakefulness
WB Britton, JR Lindahl, BR Cahn, JH Davis, RE Goldman
Annals of the New York Academy of Sciences 1307 (1), 64-81, 2014
1622014
Future directions in meditation research: Recommendations for expanding the field of contemplative science
C Vieten, H Wahbeh, BR Cahn, K MacLean, M Estrada, P Mills, M Murphy, ...
PloS one 13 (11), e0205740, 2018
1542018
Event-related delta, theta, alpha and gamma correlates to auditory oddball processing during Vipassana meditation
BR Cahn, A Delorme, J Polich
Social cognitive and affective neuroscience 8 (1), 100-111, 2013
1502013
Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
I Grant, BR Cahn
Clinical neuroscience research 5 (2-4), 185-199, 2005
982005
Critical analysis of the efficacy of meditation therapies for acute and subacute phase treatment of depressive disorders: a systematic review
FA Jain, RN Walsh, SJ Eisendrath, S Christensen, BR Cahn
Psychosomatics 56 (2), 140-152, 2015
922015
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations
M Kometer, BR Cahn, D Andel, OL Carter, FX Vollenweider
Biological psychiatry 69 (5), 399-406, 2011
762011
Effect of mindfulness-based relapse prevention on impulsivity trajectories among young adults in residential substance use disorder treatment
JP Davis, N Barr, ER Dworkin, TM Dumas, B Berey, G DiGuiseppi, ...
Mindfulness 10, 1997-2009, 2019
342019
Plasticity of visual attention in Isha yoga meditation practitioners before and after a 3-month retreat
C Braboszcz, BR Cahn, B Balakrishnan, RK Maturi, R Grandchamp, ...
Frontiers in psychology 4, 914, 2013
342013
Bid regulation of neuronal apoptosis
JR Leonard, C D’Sa, BR Cahn, SJ Korsmeyer, KA Roth
Developmental Brain Research 128 (2), 187-190, 2001
322001
Meditation and the brain in health and disease
KCR Fox, BR Cahn
262019
Neurophysiologic correlates to sensory and cognitive processing in altered states of consciousness
BR Cahn
University of California, San Diego, 2007
122007
Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD
CR Lewis, J Tafur, S Spencer, JM Green, C Harrison, B Kelmendi, ...
Frontiers in Psychiatry 14, 101, 2023
72023
Meditation states and traits
BR Cahn, J Polich
Psychology of Consciousness, 2013
52013
Effects of Online Choir or Mindfulness Interventions on Auditory Perception and Well-Being in Middle-and Older-Aged Adults During the COVID-19 Pandemic: A Randomized Controlled …
E Herschel, S Hennessy, BR Cahn, R Goldsworthy, A Habibi
Music & Science 5, 20592043221140524, 2022
32022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20